British National Formulary

For further information, see the current issue of the British National Formulary. 

British National Formulary. London British Medical Association The Pharmaceutical Press. (The chapter on drugs used in the treatment of infections is a particularly useful section. New editions of the BNF appear at regular intervals.)... 

The current British Pharmacopoeia and British National Formulary should be consulted for further information, including toxic manifestations. 

Joint Formulary Committee, ed (2009). British National Formulary. London Pharmaceutical Press. 

The proprietary names used in this book can be found in Martindale the Complete Drug Reference, although not all are listed in the British National Formulary. 

The recommended International Non-proprietary Name (rINN) is used throughout the book, except when the terms used are adrenaline and noradrenaline. For further reference, see the British National Formulary. 

From British National Formulary 40, September 2000. Liquid, tablet and powder preparations contain salbutamol as the sulphate salt aerosols contain the free base. 

The committee classified products subject to monographs in the British Pharmacopoeia (BP), British Pharmaceutical Codex (BPC) and the British National Formulary (BNF) as Category M-Products. Acceptable products other than monograph preparations were Category A-Products. All other products were Category B-Products, these were considered less effective or more toxic than those in Categories M or A or their efficacy was regarded as unproven. 

The greatest influence on doctors to prescribe well is the provision of high quality information. This has been achieved over the last decades by the British National Formulary BNF. 

Yellow cards are also found in the back of the British National Formulary, with the ABPI Data Sheet Compendium, and interleaved with National Flealth Service General Practitioner FPIO prescription forms. 

British National Formulary published every six months by the British Medical Association and the Royal Pharmaceutical Society of Great Britain... 

From 1976 to 1984 John Griffin served on the Joint Formulary Committee of the British National Formulary, during which period the first eight issues of the current format were produced. 

Martin J, editor. British national formulary. 53rd ed. London BMJ Publishing and RPS Publishing 2007. 

Intramuscular haloperidol is a suitable drug for tranquillizing violent patients, but it can be difficult to determine the correct dosage, and there is the risk of an acute dystonic reaction, particularly in younger patients. The British National Formulary recommends intramuscular injections of from 2 to 10 mg, subsequent doses being given after 4-8 hours but in exceptional cases, initial doses of up to 30 mg may be necessary. 

Table 2 gives details of some conventional regimes (see British National Formulary, 2008). The efficacy of therapy can be checked by Radiocarbon-labelled urea breath testing (which depends upon release of labelled carbon dioxide by bacterial urease) or by testing gastric biopsy material for persistence of gastric urease, but should only be done after eradication therapy has been discontinued for at least a month, and whilst any anti-secretory treatment has been discontinued (because it tends to suppress but does not eradicate the organism). 

British National Formulary (2008). Vol 55 Broekaert E Vanderplasschen W (2003). Towards the integration of treatment systems for substance abusers Report on the Second International Symposium on Substance Abuse Treatment and Special Target Groups. Journal of Psychoactive Drugs, 35, 237-45... 

British National Formulary, No. 3, 1982 , British Medical Association and The... 

British National Formulary, Diamorphine, http //bnf.org/bnf/bnf/current/noframes/3521.htm, 2003. Accessed January 12, 2004. 

British Medical Association and Pharmaceutical Society of Great Britain 1963, British National Formulary, Alternative Edition, based on a pharmacological classification edn, British Medical Association and Pharmaceutical Society of Great Britain, London. 

The following year, the British National Formulary, a joint publication of the British Medical Association and Royal Pharmaceutical Society of Great Britain (1991), listed suicidal ideation and violent behavior as fluoxetine side effects. Also in 1991,1 published Toxic Psychiatry, in which I observed for the first time that Prozac was producing a continuum of overstimulation that included akathisia, agitation, anxiety, insomnia, depression and mania, and, in the extreme, suicide and violence. I drew on previously sequestered FDA premarketing data on Prozac, the scientific literature, and my own clinical and forensic cases. 

British Medical Association and Royal Pharmaceutical Society of Great Britain. (1991, September). British national formulary (BNF). London Pharmaceutical Press. Brodal, A. (1969). Neurological anatomy. New York Oxford University Press. 

---